0.75Open0.11Pre Close9 Volume512 Open Interest15.00Strike Price295.00Turnover111.88%IV19.11%PremiumDec 20, 2024Expiry Date0.00Intrinsic Value100Multiplier17DDays to Expiry0.10Extrinsic Value100Contract SizeAmericanOptions Type-0.1625Delta0.0556Gamma43.34Leverage Ratio-0.0321Theta-0.0015Rho-7.04Eff Leverage0.0097Vega
MediWound Stock Discussion
·3 mins ago
Mediwound Announces U.S. Food and Drug Administration Approval of Nexobrid® for the Treatment of Pediatric Patients With Severe Thermal Burns
No comment yet